HGH 191AA
Somatropin
HGH 191AA denotes the 191-amino-acid human growth hormone. Somatropin medicines have defined medical indications.
Approvals
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
HGH 191AA denotes somatropin, the 191-amino-acid form of human growth hormone. Evidence and approval apply to defined medicinal products.
- Human research
- Strong
- Replication
- No independent replication
- Clinical endpoints
- Hard patient-relevant outcomes
- Safety
- Characterized by prescribing information or extensive studies
- Approval
- US · Approved
The dimensions are presented separately and are not combined into an overall score.
What the source shows
GENOTROPIN is approved for conditions including growth hormone deficiency, not general anti-aging.
- GENOTROPIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed:
Research gaps
- ·A catalogue vial is not automatically equivalent to an approved medicine.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
Growth hormone affects growth and metabolism directly and through IGF-1.
- GENOTROPIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Fluid retention and impaired glucose regulation may occur.
Contraindications and warnings
- ·Contraindications include active malignancy and certain acute critical illnesses.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·A catalogue vial is not automatically equivalent to an approved medicine.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- GENOTROPIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed:
Sources
Sources checked: · Version 2
- GENOTROPIN: US prescribing informationPrescribing information2026
U.S. National Library of Medicine (DailyMed)
Accessed: